After discontinuing its internal GLP-1 in May of 2025 for causing liver issues, Pfizer won a bidding war against seven other companies for Metsera, which is developing a variety of incretin assets, paying $10 billion in one of 2025s largest M&A deals
At Maryland Trim Clinic, GLP-1 services are positioned within a broader medical weight-management approach that includes assessment, follow-up, nutrition guidance, and progress monitoring
If you prefer asynchronous care without video visits, Noom makes it seamless
Misuse of Vyvanse can lead to serious side effects, including heart problems and, in some cases, death
Start with light weights, focus on learning the movement patterns, and build gradually
The flushing reflects vasodilation related to growth hormone release and carries no health concerns